First Time Loading...

Arvinas Inc
NASDAQ:ARVN

Watchlist Manager
Arvinas Inc Logo
Arvinas Inc
NASDAQ:ARVN
Watchlist
Price: 32.82 USD 1.2% Market Closed
Updated: May 4, 2024

Wall Street
Price Targets

ARVN Price Targets Summary
Arvinas Inc

Wall Street analysts forecast ARVN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ARVN is 71.29 USD with a low forecast of 38.38 USD and a high forecast of 115.5 USD.

Lowest
Price Target
38.38 USD
17% Upside
Average
Price Target
71.29 USD
117% Upside
Highest
Price Target
115.5 USD
252% Upside

ARVN Last Price Targets
Arvinas Inc

The latest public price target was made on Apr 12, 2024 by Andrew Fein from H.C. Wainwright , who expects ARVN stock to rise by 165% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Andrew Fein
H.C. Wainwright
87 USD
Upside 165%
3 weeks ago
Apr 12, 2024
Arvinas Inc. (ARVN) PT Lowered to $87 at H.C. Wainwright on Novartis deal
StreetInsider
Bradley Canino
Stifel Nicolaus
72 USD
Upside 119%
3 weeks ago
Apr 11, 2024
Arvinas Inc. (ARVN) PT Raised to $72 at Stifel, 'strong case to increase ARV-766 sales estimates'
StreetInsider
Derek Archila
Wells Fargo
63 USD
Upside 92%
4 months ago
Dec 19, 2023
Wells Fargo Upgrades Arvinas Inc. (ARVN) to Overweight, 'risk/reward is highly favorable'
StreetInsider
Robert Driscoll
Wedbush
24 USD
Downside 27%
6 months ago
Oct 23, 2023
Wedbush Upgrades Arvinas Inc. (ARVN) to Outperform
StreetInsider
Andrew Fein
H.C. Wainwright
Price Target 87 USD
Upside/Downside 165%
View Source
Bradley Canino
Stifel Nicolaus
Price Target 72 USD
Upside/Downside 119%
View Source
Derek Archila
Wells Fargo
Price Target 63 USD
Upside/Downside 92%
View Source
Robert Driscoll
Wedbush
Price Target 24 USD
Upside/Downside 27%
View Source
Arvinas Inc Competitors:
Price Targets
300452
Anhui Sunhere Pharmaceutical Excipients Co Ltd
40% Upside
NATCOPHARM
Natco Pharma Ltd
11% Downside
000538
Yunnan Baiyao Group Co Ltd
11% Upside
000739
Apeloa Pharmaceutical Co Ltd
50% Upside
GRIN
Grown Rogue International Inc
30% Downside
GS71
GSK plc
12% Upside
002275
Guilin Sanjin Pharmaceutical Co Ltd
11% Upside

Revenue
Forecast

Revenue Estimate
Arvinas Inc

For the last 6 years the compound annual growth rate for Arvinas Inc's revenue is 48%. The projected CAGR for the next 3 years is 57%.

48%
Past Growth
57%
Estimated Growth
Estimates Accuracy
2%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Arvinas Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

Net Income
Forecast

Net Income Estimate
Arvinas Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-31%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ARVN's stock price target?
Price Target
71.29 USD

According to Wall Street analysts, the average 1-year price target for ARVN is 71.29 USD with a low forecast of 38.38 USD and a high forecast of 115.5 USD.

What is Arvinas Inc's Revenue forecast?
Projected CAGR
57%

For the last 6 years the compound annual growth rate for Arvinas Inc's revenue is 48%. The projected CAGR for the next 3 years is 57%.